Priority Date: 15.06.12 (GB 20120010686)

V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL

  • Application ID: EP13729363
  • Status: GRANT OF PATENT INTENDED

Attorney

operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61, C07, and G01 is specialized in the combination A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Vereenigde Octrooibureaux NV (V.O.) and 57 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 15.06.2012 - Priority Date (GB 20120010686)
  • 19.12.2013 - Publication A1 (WO2013186399)
  • 22.04.2015 - Publication A1 (EP2861253)